ODQ is a highly selective, irreversible, heme-site inhibitor of soluble guanylyl cyclase.1,2 The binding of ODQ is competitive with NO. The inhibition of soluble guanylyl cyclase is time dependent with complete inactivation in 10 minutes at 0.3 µM ODQ.2
1
Garthwaite, J., Southam, E., Boulton, C.L., et al. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol48184-188(1995).
2
Schrammel, A., Behrends, S., Schmidt, K., et al. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol501-5(1996).
Schrammel, A., Behrends, S., Schmidt, K., et al. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol501-5(1996).
Garthwaite, J., Southam, E., Boulton, C.L., et al. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol48184-188(1995).
ODQ is available in the following screening
library: